Published in Infection on January 01, 1988
Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41
Therapeutic activities of antibiotics in listeriosis. Infection (1991) 0.82
Cellular resistance to infection. J Exp Med (1962) 30.96
The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med (1969) 20.62
Listeria monocytogenes and listeric infections. Bacteriol Rev (1966) 11.43
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Listeria monocytogenes infection in nude mice. Infect Immun (1975) 2.82
Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. J Exp Med (1985) 2.37
Immunological aspects of leprosy--present status. Prog Allergy (1978) 2.37
On the mechanism of T cell-independent anti-Listeria resistance in nude mice. J Immunol (1980) 2.20
Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains. Infect Immun (1980) 1.97
H-2K-restricted granuloma formation by Ly-2+ T cells in antibacterial protection to facultative intracellular bacteria. J Immunol (1985) 1.50
Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity. Immunology (1985) 1.35
Dynamics of T cells of L3T4 and Ly 2 phenotype within granulomas in murine listeriosis. Clin Exp Immunol (1985) 1.33
Models of T cell deficiency in listeriosis: the effects of cortisone and cyclosporin A on normal and nude BALB/c mice. J Immunol (1983) 1.22
Morphological changes induced by dextran sulfate 500 in mononuclear phagocytes of listeria-infected mice. Infect Immun (1974) 1.17
Morphology and time course of experimental listeriosis in nude mice. Infect Immun (1976) 1.11
Ontogeny of macrophage-mediated protection against Listeria monocytogenes. Infect Immun (1985) 1.08
Animal experimental studies on chronic granulomatous inflammation and T-lymphocyte-system. Beitr Pathol (1975) 1.03
Reversion of dextran sulfate-induced loss of antibacterial resistance by Bordetella pertussis. Infect Immun (1978) 0.96
Effect of aging on antimicrobial immunity: old mice display a normal capacity for generating protective T cells and immunologic memory in response to infection with Listeria monocytogenes. J Immunol (1985) 0.96
Course of infection and development of immunity in experimental infection of mice with Listeria serotypes. Infect Immun (1983) 0.93
Effects of cyclosporin A on experimental infection with Listeria monocytogenes. Clin Exp Immunol (1985) 0.92
The processing and presentation of Listeria monocytogenes antigens by macrophages. Clin Invest Med (1984) 0.89
Effect of cyclosporin A on immunity to Listeria monocytogenes. Infect Immun (1986) 0.85
Resistance of gnotobiotic nude mice to Listeria infection. Ann Immunol (Paris) (1984) 0.79
Natural resistance to listeriosis: role of host inflammatory responsiveness. Clin Invest Med (1984) 0.79
Modulation of epithelioid cell granuloma formation to apathogenic mycobacteria by cyclosporin A. Pathol Res Pract (1982) 0.79
Macrophage function in senescence. Gerontology (1982) 0.76
Protection against facultative intracellular bacteria--role of macrophage activation and granuloma formation. Infection (1985) 0.75
Murine model for therapy of listeriosis in the compromised host. IV. Cotrimoxazole. Chemotherapy (1985) 0.75
Neonatal listeriosis: where do we go from here? Pediatr Infect Dis (1985) 0.75
Causative agents, mediators and histomorphology of inflammation. Pathol Res Pract (1985) 0.75
Tn916-induced mutations in the hemolysin determinant affecting virulence of Listeria monocytogenes. J Bacteriol (1987) 7.18
Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis (2000) 3.09
Listeria monocytogenes infection in nude mice. Infect Immun (1975) 2.82
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect Immun (1983) 2.60
Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature (1982) 2.38
Virulence of different strains of Listeria monocytogenes serovar 1/2a. Med Microbiol Immunol (1984) 2.31
Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol (2005) 2.30
Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol (1995) 2.24
Cell-mediated resistance to infection with Listeria monocytogenes in nude mice. Infect Immun (1977) 2.08
Levels of Listeria monocytogenes hemolysin are not directly proportional to virulence in experimental infections of mice. Infect Immun (1988) 1.95
Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol (1997) 1.84
Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Med Microbiol (2001) 1.79
A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J Immunol (2001) 1.75
Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci U S A (2000) 1.65
[Special position of strongly haemolytic strains of the genus Listeria]. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 1.62
What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis (2010) 1.58
Intracerebral targets and immunomodulation of murine Listeria monocytogenes meningoencephalitis. J Neuropathol Exp Neurol (1996) 1.54
Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol (1999) 1.51
[Campylobacter fetus subsp. fetus in a patient with liver cirrhosis]. Immun Infekt (1994) 1.38
[Acute purulent Listeria seelingeri meningitis in an immunocompetent adult]. Schweiz Med Wochenschr (1986) 1.34
Marker exchange mutagenesis of the aerolysin determinant in Aeromonas hydrophila demonstrates the role of aerolysin in A. hydrophila-associated systemic infections. Infect Immun (1987) 1.31
Phosphatidylcholine-specific phospholipase C from Listeria monocytogenes is an important virulence factor in murine cerebral listeriosis. Infect Immun (1998) 1.22
Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect Immun (2001) 1.22
Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system. Infect Immun (1992) 1.22
Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J Immunol (1998) 1.22
Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun (1999) 1.22
Accelerated and prolongated multiplication of antibody-forming spleen cells by Bordetella pertussis in mice immunized with sheep red blood cells. Experientia (1967) 1.20
Isolation of Corynebacterium group JK from clinical specimens with a semiselective medium. J Clin Microbiol (1984) 1.19
Dependence of fatty acid composition of Listeria spp. on growth temperature. Res Microbiol (1993) 1.18
Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice. Immunology (1995) 1.15
Adjuvant treatment of brain metastases. Semin Surg Oncol (2001) 1.12
Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol (1997) 1.11
Morphology and time course of experimental listeriosis in nude mice. Infect Immun (1976) 1.11
Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. Infect Immun (1994) 1.10
Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria. Antimicrob Agents Chemother (1982) 1.09
Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J Neuroimmunol (1991) 1.08
Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine (2001) 1.08
Listeriosis in Germany. Ger Med Mon (1969) 1.07
Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J Immunol (1998) 1.07
Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study. J Neuropathol Exp Neurol (1994) 1.06
[Pathogenicity of Listeria]. Immun Infekt (1986) 1.04
Influence of cloned Escherichia coli hemolysin genes, S-fimbriae and serum resistance on pathogenicity in different animal models. Microb Pathog (1986) 1.04
Persistent wound infection after herniotomy associated with small-colony variants of Staphylococcus aureus. Infection (2000) 1.04
Detection and identification of Candida species in experimentally infected tissue and human blood by rRNA-specific fluorescent in situ hybridization. J Clin Microbiol (1997) 1.03
Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children. Rev Inst Med Trop Sao Paulo (1975) 1.03
Pseudoappendicitis caused by Plesiomonas shigelloides. J Clin Microbiol (1988) 1.01
Failure of synthetic muramyl dipeptide to increase antibacterial resistance. Infect Immun (1980) 1.00
Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1996) 0.99
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. Breast (2012) 0.99
Failure of cephalosporins to cure experimental listeriosis. J Infect (1984) 0.98
[Effect of Bordetella pertussis on the lymphatic tissue of mice. II. Proliferating cell systems in the spleen after the injection of Bordetella pertussis]. Z Med Mikrobiol Immunol (1968) 0.98
Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother (1994) 0.97
Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab Invest (1996) 0.97
[Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria]. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.97
Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures. Vox Sang (2010) 0.97
Reversion of dextran sulfate-induced loss of antibacterial resistance by Bordetella pertussis. Infect Immun (1978) 0.96
The neuropathology of galactosemia. A histopathological and biochemical study. J Neuropathol Exp Neurol (1971) 0.95
[Structure and biological activity of Bordetella pertussis endotoxin (proceedings)]. Zentralbl Bakteriol Orig A (1976) 0.95
Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur J Immunol (2000) 0.95
Onychomycosis. Mycoses (2007) 0.94
[Effect of Bordetella pertussis on the lymphoid tissue o mice. 3. Effect on the kinetics of formation of antibodies against sheep erythrocytes by Bordetella pertussis]. Z Immunitatsforsch Allerg Klin Immunol (1969) 0.94
[Experimental studies on the importance of the imidazole rings for the association capacity of insulin molecules]. Biochim Biophys Acta (1966) 0.94
Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua. J Immunol (1999) 0.94
Time Relationships Between Injection of Antigen and Adjuvant I. Adjuvancy of Bordetella pertussis Given at Various Times Before the Primary Antigenic Stimulus. Infect Immun (1970) 0.94
Clinical significance of resistant corynebacteria group JK. Lancet (1983) 0.93
Course of infection and development of immunity in experimental infection of mice with Listeria serotypes. Infect Immun (1983) 0.93
Symptoms and complications of pertussis in adults. Infection (1996) 0.93
Antibacterial activities of nitrothiazole derivatives. J Antimicrob Chemother (1984) 0.93
Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis (2002) 0.93
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment. Radiat Oncol (2006) 0.92
Use of fosfomycin disks for isolation of diphtheroids. Eur J Clin Microbiol Infect Dis (1988) 0.92
Molecular analysis of bacterial cytolysins. Rev Infect Dis (1988) 0.92
Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect Immun (2001) 0.92
Effects of cyclosporin A on experimental infection with Listeria monocytogenes. Clin Exp Immunol (1985) 0.92
Age-related defense against infection with intracellular pathogens. Gerontology (1979) 0.91
Antibacterial effects of niridazole: its effect on microaerophilic campylobacter. Infection (1984) 0.90
Antibacterial effects of niridazole. I. Effect on infection of mice with Salmonella typhimurium. Chemotherapy (1982) 0.90
Rapid detection of susceptibility to fluconazole in Candida species by a bioluminescence assay of intracellular ATP. Diagn Microbiol Infect Dis (1996) 0.90
Variable Adjuvant Activity of Bordetella pertussis with Respect to the Primary and Secondary Immunization of Mice. Infect Immun (1970) 0.90
Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J Neuroimmunol (1997) 0.89
Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection. Eur J Clin Microbiol Infect Dis (1994) 0.89